Mineralys Therapeutics In... (MLYS)
NASDAQ: MLYS
· Real-Time Price · USD
13.67
0.22 (1.64%)
At close: Jun 17, 2025, 12:13 PM
Mineralys Therapeutics Revenue
Mineralys Therapeutics reported an annual revenue of $0, reflecting a 0% growth. For the quarter ending March 31, 2025, Mineralys Therapeutics generated $0 in revenue.
Revenue (ttm)
$0
Revenue Growth
0%
Price / Sales Ratio
0
Revenue / Employee
$0
Employees
51
Market Cap
890.95M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|